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Introduction: Brain insulin receptors (IRs) have been suggested as an 
important regulatory factor for cognitive functions but the involvement of IR 
signaling in memory deficit associated with neurodegenerative conditions is not 
yet explored.  Among the diverse signaling pathways of IR, PI-3 kinase and 
(MAP) kinase pathways in brain have been suggested for learning and memory 
functions. The phosphoinositide3-kinase (PI3K) complex plays important roles 
in virtually all cells of the body. The enzymatic activity of PI3Kto 
phosphorylate phosphoinositides in the membrane is mediated by a group of 
catalytic and regulatory subunits. Among those, the class I catalytic subunits, 
p110α, p110β,p110γ,and p110δ have recently drawn attention in the 
neuroscience field due to their specific dysregulation in diverse brain disorders. 
The present study was planned to investigate the effect of PI3K on memory. 
Materials and Methods: The animals were injected bilaterally with ICV water 
(control group), ICV PI3k (1,10 and 100 ng/rat) on days 1 and 3 after surgery.  
The learning and memory performance was assessed two weeks after the first 
dose of drugs by using step-through passive avoidance paradigm (0.3 mA, 
3seconds) and open field test. The results revealed that The ICV administration   
of PI3K (P<0.05) altered inhibitory avoidance acquisition. PI3K at dose 1 
ng/rat decreased the step- through latency during the retention test. 
Results: data showed that PI3K at dose of 1 ng/rat decreased the step- through 
latency during the retention test. In addition, the results showed that PI3K at 
dose 10 ng/rat increased locomotor activity.  
Conclusion: Finally, our data indicated that PI3K has critical role in memory 
consolidation and locomotor activity. 
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     The presence of brain insulin receptors 
(IRs) in the hippocampus suggests its 
functional involvement in cognition [1]. 
Hippocampal IR system might play an 
important role in the regulation of memory 
functions [2, 3]. Moreover, deregulation of 
brain IR has been linked to the pathogenesis 
of age-related neurodegenerative disorders 
such as Alzheimer's [4] and Parkinson's 
disease [5]. 
The molecular cascades downstream from 
IR are composed of a large number of 
signaling molecules including insulin 
receptor substrates (IRSs) and Src 
homology 2 (SH2) and SH2-SH3 domain-
containing proteins. Among the diverse 
signaling pathways of IR, insulin receptor 
substrate-1 (IRS- 1)/PI-3 
kinase/phosphoinositide-dependent kinase 
(PDK)/ protein kinase B (PKB/Akt) and the 
Src homology and collagen protein 
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(Shc)/growth factor receptor-bound protein-
2 (Grb2)/mitogen-activated protein (MAP) 
kinase pathways in brain have been 
suggested for learning and memory 
functions [6]. 
Studies showed that the formation of long-
term extinction memory is associated with 
activation of kinase cascades, transcription 
factors, and proteins [7-9]. The 
phosphoinositide 3-kinase (PI3K) has been 
found vital for cell proliferation and 
prevention of apoptosis. A well-documented 
PI3K downstream target is AKT/ protein 
serine/threonine kinase (PKB); the 
activation of AKT is usually dependent on 
PI3K, and its phosphorylation is blocked by 
PI3K inhibitors. Increasing evidence 
indicates that PI3K has a role in mediating 
the formation of memory [9-11]. 
Further, extracellular signal-regulated 
kinase (ERK) can be activated by other 
signaling cascades that are critical for 
Hippocampal-dependent memory 
formation, including phosphatidylinositol 3-
kinase/Akt (PI3K/Akt) [12]. PI3K is crucial 
for hippocampal plasticity and object 
recognition [10, 13, 14], is vital for 
neuroprotection [15], which could be 
critically important for the aging brain. 
Signaling through phosphoinositide 3-
kinases (PI3Ks) has diverse roles in the 
human body, regulating essential functions 
such as cell growth, migration, 
differentiation and survival. PI3K signaling 
is important for an adequate immune 
response [16], hematopoiesis [17], and 
organ growth [18]. Mutations in PI3K 
catalytic subunits were found in primary 
immune deficiencies [19] and in different 
forms of human cancer, including leukemia 
[20, 21]. Apart from a role in dividing cells, 
PI3K activity is also a key regulator of 
neuronal function. PI3K signaling 
transduces signals from cell surface 
receptors to the Akt/ mammalian target of 
rapamycin (mTOR) pathway and is 
essential for synapse and dendritic spine 
development [22-25] and for enduring 
forms of synaptic plasticity underlying  
learning and memory [26-30]. Therefore, it 
is not surprising that an increasing body of 
evidence suggests dysregulated PI3K 
activity and down-stream signaling as a key 
contributor and potential therapeutic target 
for mental disorders [31-35]. 
In vertebrates, PI3K enzymatic activity is 
brought about by eight different catalytic 
subunits. These catalytic subunits are 
divided into class I, class II, and class III. 
PI3K enzymes according to their protein 
structure, function and associate with 
regulatory subunits [36]. Most recently, 
p110 subunit-specific functions and 
mechanisms have begun to be discovered in 
the brain. The different p110 isoforms 
appear to have unique roles in mediating 
distinct forms of neuronal function and 
synaptic plasticity, suggesting the use of 
subunit-selective p110 inhibitors for certain 
brain disorders. The importance of PI3K 
catalytic subunit-selective roles in neurons 
is illustrated by functional and genetic 
studies that have linked dysregulation or 
mutations of specific p110 isoforms with 
distinct brain disorders. Given the essential 
function of PI3K signaling in non-neuronal 
cells, a precise knowledge of the molecular 
mechanisms of neuron-specific PI3K 
enzyme regulation and dysregulation in 
disease is mandatory for the development of 
therapeutic strategies ameliorating brain 
disorders without compromising other 
essential functions of the body [37]. 
Considering the involvement of IR and its 
signaling pathways in the hippocampus,The 
present study was planned to investigate 
neuroprotective effects of PI3K on memory 
formation. For this purpose,we examined 
the effect of ICV administration of PI3K in 
acquisition of inhibitory avoidance memory. 
 
2. Materials and Methods 
2.1. Animals 
     Adult Male Wistar rats, weighting 200-
220 g were purchased from Pasteur 
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Institute, Tehran, Iran. There were 8 rats in 
each group. Animals were housed in  
standard cages under controlled room 
temperature (22–24 °C), humidity (45–
50%) and light exposure conditions 12:12 h 
light–dark cycle (light on at 08:00 am). All 
experiments were carried out during the 
light phase of the cycle (8:00 am–3:00 pm). 
The animals had unrestricted access to food 
and water. Animals were allowed to adapt 
to the laboratory conditions for at least 1 
week before surgery. All experiments were 
performed between 9:00 and 15:00 and each 
rat was tested only once. All procedures in 
this study are in accordance with the guide 
for Care and Use of Laboratory Animals as 
adopted by the Ethics Committee of Faculty 




     The following drug was used in the 
experiments: PI3K (Sigma-Aldrich 
Company, USA, stored at −80 °C). 
The drug was administered 
intracerebroventricularly (ICV) twice at an 
interval of 48 on days 1 and 3 after 
cannulation. PI3K at dose of 1,10 and 100 
ng/rat dissolved in 2 μl sterile 
deionized/distilled water and 1μl injected 
slowly by micro liter syringe (Hamilton) on 
each side using the coordinates.  
The infusion process lasted 2 to 3 minutes. 
One minute after infusion, the needle was 
removed very slowly from the site. The 
infusion process lasted 2 to 3 minutes. One 
minute after infusion, the needle was 
removed very slowly from the site. 
 
2.3. Intracerebroventricular (ICV) 
Injection  
     The rats were anesthetized by i.p. 
infusion of Ketamine (60mg/kg) and 
Xylazine (6 mg/kg) mixture, and their heads 
were placed in stereotax apparatus. Located 
in a site (AP= - 0.8 mm; ML= ±1.4 mm; 
DV= 3.6 mm) based on the rat brain atlas, 
each guide cannulae was positioned with a 
0.5 mm distance from the lateral ventricles 
level. The cannulae were secured to the 
bone with dental acrylic crement. 
2.4. Passive Avoidance Task 
     Passive avoidance memory test 
performance was examined on the 14th day 
after 1st day of the injection. The apparatus 
used for the passive avoidance task was the 
two-way shuttle box (BorjSanaatAzma Co., 
Tehran, Iran), which consisted of an 
illumination compartment with identical 
dimensions (30 cm × 20 cm × 20 cm) made 
of transparent plastic and of a dark 
compartment (30 cm × 20 cm × 20 cm), the 
walls and ceiling which were made of dark 
opaque plastic. A rectangular opening (8 cm 
× 8 cm) was located between the two 
chambers and could be closed by an opaque 
guillotine door. The grid floors of both 
chambers were made of stainless steel rods 
(2mm diameter), spaced 1 cm apart. The 
apparatus was kept in an acoustically 
insulated room, under standard conditions. 
The experiment consisted of adaptation, 
training and memory retention sessions. In 
the adaptation session, rats were put into the 
illuminated compartment and allowed to 
enter the dark compartment. After the rats 
entered the dark compartment, the door was 
closed and the rats were returned to their 
home cages. After 30 min of adaptation, the 
rats were placed in the illuminated 
compartment for the training session. After 
the rats entered the dark compartment, the 
door was closed and an electric shock (0.3 
mA, 50 Hz 3 seconds) was delivered from 
the steel-rod floor. Rats were allowed to 
explore the light compartment for 20 sec 
before the door to the dark compartment 
was opened. The latency to step into the 
dark compartment was recorded (pre-shock 
latency). After 20 sec, the rats were returned 
to their home cages. Two minutes later, rats 
were placed in the illuminated compartment 
for 20 sec and after opening the door, the 
latency of stepping into the dark 
compartment was recorded. If latency was 
greater than 120 sec (post-shock latency), 
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the rats were returned to their home cages 
and acquisition trial was performed. If 
latency was less than 120 sec, the shock 
would be repeated. Memory retention was 
checked 24 h later. The rats were placed in 
the illuminated compartment for 20 sec and 
after opening the door, the latency of 
stepping into the dark compartment was 
recorded (test latency) up to a maximum of 
5 min. No shock was delivered during the 
test session. 
 
2.5. Open Field Test 
     Immediately after the inhibitory 
avoidance test session, the animals were 
transferred to an open-field test. The open 
field apparatus was constructed of white 
plywood and measured 72 × 72 cm with 
walls 36 cm high. One of the walls was 
clear Plexiglas, so rat could be visible in the 
2 apparatus. Blue lines were drawn on the 
floor with a marker and were visible 
through the clear Plexiglas floor. The lines 
divided the floor into sixteen 18 × 18 cm 
squares. A central square (18 cm × 18 cm) 
was drawn in the middle of the open field 
[38]. The central square is used because 
some rat strains have high locomotor 
activity and cross the lines of the test 
chamber many times during a test session. 
Also, the central square has sufficient space 
surrounding it to give meaning to the central 
location as being distinct from the outer 
locations [39]. The open field session lasted 
for 5 min and during this time, an observer, 
who was not aware of the pharmacological 
treatments, recorded the number of crossing 
responses and rearing responses manually. 
This test was carried out to identify motor 
disabilities, which might influence 
inhibitory avoidance performance at testing 
[40]. 
 
2.6. Statistical Analysis  
     Since data displayed normality of 
distribution and homogeneity of variance, 
the results were statistically evaluated by 
analysis of variance one-way (ANOVA). 
Results were expressed as mean ±S.E.M. 
and the statistical analysis was done through 
one-way analysis of variance (ANOVA), 
followed by the Newman–Keuls (post –hoc 
analysis) test to determine the significance 
of difference among various groups. The p-




     One-way ANOVA analysis revealed that 
ICV administration of PI3K [F (3, 28) 
=5.1681, P<0.05, Fig.1A], altered inhibitory 
avoidance acquisition. Moreover, post hoc 
analysis showed that PI3K at a dose of 1 
ng/rat decreased the step-through latency 
during the retention test and the other doses 
had no effect on memory formation using 
the passive avoidance task. 
In addition, one-way ANOVA showed that 
PI3K [F (3, 28) =16.190, P<0.01, Fig.1B], 
at a dose of 10 ng/rat increased locomotor 
activity and the other doses had no effect on 
locomotor activity using the open field test.  








Figure 1. The effect of PI3K on memory and locomotor activity. The animals received ICV PI3 K or sterile 
deionized/distilled water according to the table. All drugs were injected on day 1 and 3 after surgery. The memory was 
measured two weeks after first dose ICV injection. B showed the effect of drugs on locomotor activity in test day. Data 
are expressed as mean ±S.E.M of eight animals per group. +P<0.05 and ++P<0.01 different from sterile 
deionized/distilled water/PI3K control group 
 
4. Discussion 
     In our study, data revealed that ICV 
administration of PI3K altered inhibitory 
avoidance acquisition. Moreover, the 
analysis showed that PI3K at a dose of 1 
ng/rat decreased the step-through latency 
during the retention test. In addition, the 
results showed that PI3K, at a dose of 10 ng 
increased locomotor activity.  
This is the first time that ICV administration 
of PI3K is examined in memory 
experiments. Extensive evidence showed 
that AKT is the main kinase of the 
phosphoinositide 3-kinase cascade (PI3K) 
and has been implicated in long-term 
memory but in these experiments, all 
researchers used the inhibitors of AKT or 
ERK kinase pathways.  
The other findings provide additional 
evidence suggesting that targeting PI3K has 
differential effects depending on the 
temporal and spatial parameters of time and 
site of injection [11, 41]. The presumed 
involvement of AKT in synaptic plasticity 
and memory processes suggests that its 
phosphorylation levels should be changed 
when learning occurs. The results show 
different activation of AKT following 
conditioned taste aversion (CTA) 
conditioning and extinction. Surprisingly, 
although AKT is a downstream target of 
PI3K which undergoes dephosphorylation 
following extinction, its inhibition is not 
obligatory for CTA acquisition or extinction 
[42]. Alterations in IR expression in 
membrane fraction of CA1 and CA3 may be 
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linked with learning and memory (6). A 
significant increase in IR/IRS-1/Akt 
pathway, including IRS-1 and Akt 
phosphorylation was observed after water 
maze training in membrane in these regions. 
Increase in Akt phosphorylation consistent 
with the up-regulation of Akt gene 
expression in spatial learning has been 
reported [43].  
The observations point out that IR signaling 
pathways are associated with learning and 
memory and the brain IRs are more 
susceptible to oxidative stress than to 
cholinergic activity [44]. 
Some results showed that while AKT 
phosphorylation was increased following 
CTA learning, it was decreased following 
CTA extinction. Inhibition of AKT 
phosphorylation in the IC before or after the 
first CTA retrieval test resulted in reduction 
of the aversion index as re-application of 
the unconditioned stimulus (lithium 
chloride) and did not induce the recovery of 
aversion in LY294002-treated animals. 
These data also added new evidence to 
suggest that PI3K was engaged in 
consolidation of aversive memories, as its 
inhibition was associated with erasure of 
CTA memory [45]. The other findings 
confirmed that PI3K was not involved in the 
retrieval of CTA memory [11, 12]. 
Therefore, the result also showed different 
activation of AKT following CTA 
conditioning and extinction. Specifically, in 
the IC, the levels of p-AKT were 
dramatically increased after CTA 
conditioning, compared with the control 
group and extinction training was associated 
with dephosphorylation of AKT following 
the extinction session [9].  
It has been shown that Protein Kinase A 
(PKA) was activated by cyclic-AMP. 
Inhibition of PKA at the time of retrieval of 
CTA in the BLA resulted in rapid extinction 
[46, 47]. Another data added new evidence 
to suggest that PI3K was engaged in 
consolidation of aversive memories, as its 




     ICV administration of PI3K in some 
doses had effect on memory consolidation, 
altered inhibitory avoidance acquisition and 
locomotor activity. PI3K at a dose of 1 
ng/rat decreased the step-through latency 
during the retention test. In addition, the 
PI3K, at dose 10 ng increased locomotor 
activity. Moreover, data showed that PI3K 
at dose of 1 ng/rat decreased the step-
through latency during the retention test. In 
addition, the results showed that PI3K at 
dose 10 ng/rat increased locomotor activity. 
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